Device Reforms At Crossroads: Will User Fee Momentum Reach Critical Mass?
This article was originally published in The Gray Sheet
Device user fee advocates have a window of opportunity in which to capitalize on support from Senate HELP Committee leaders in pushing the proposal through Prescription Drug User Fee Act reauthorization this year
You may also be interested in...
House Energy & Commerce Committee Chairman Billy Tauzin (R-La.) will work with medical device reform bill sponsors to move HR 3580 independently of Prescription Drug User Fee Act reauthorization
Senate Health, Education, Labor & Pensions (HELP) Committee staffers are actively considering device user fee language for inclusion in the Prescription Drug User Fee Act reauthorization this year
HIMA LOBBYING IN SUPPORT OF DEVICE USER FEE BILL is focused on key members of the House and Senate committees that will consider the measure. The Health Industry Manufacturers Association is attempting to persuade opponents of the bill, introduced July 12, not to set up obstacles to its passage, arguing that if the measure fails Congress could end up adopting legislation that is less friendly to industry.